3D-printed corneas restore vision in first transplant, offering hope for millions

Israeli company Precise Bio has performed the world's first transplant of a lab-grown, 3D-printed cornea, offering a potential solution to the global shortage of donor tissue. The procedure aims to restore vision in millions affected by corneal blindness. The implant is created from a single donor cornea, expanded into cells to produce over 400 new corneas. It features a higher cell density than natural tissue and is designed for easier surgical handling. A Phase I safety trial is underway. The first patient, legally blind for 14 years, can now see normally nine months post-surgery. The company plans U.S. commercial distribution by 2030, pending FDA approval and further trials.